To compare ropivacaine for spinal saddle block for two different sitting duration in fistula in ano surgery
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/02/049410
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA physical status I and II of either sex.
2. Age between 18 to 65 years.
3. BMI 20 to 35 kg/m2
4. Scheduled for FIA surgery.
Exclusion Criteria
1. Refusal by the patient.
2. Patients with coagulopathy and bleeding disorder.
3. Pre-existing local infection at the site of saddle block.
4. Pregnant or lactating women.
5. Contraindications or allergy to ropivacaine and diclofenac.
6. Patients having hemodynamic instability.
7. Patients having sensory or motor problems in the lower limbs.
8. Patients having pain in any area other than surgery site.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the discharge readiness between 1 and 2 minutes of sitting after saddle block with hyperbaric ropivacaine in patients undergoing Fistula-in-Ano surgeryTimepoint: 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours
- Secondary Outcome Measures
Name Time Method 1. To assess any complications like hypotension, urinary retention, postoperative nausea/vomiting, headache and backache. <br/ ><br>2. To assess visual analogue scale (VAS) at rest and on movement. <br/ ><br>3. To calculate mean analgesic consumption of diclofenac up to 24 hours. <br/ ><br>4. To evaluate surgeon satisfaction score.Timepoint: 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours